Manulife (Manufacturers Life Insurance)
SANA icon

Manulife (Manufacturers Life Insurance)’s Sana Biotechnology SANA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$229K Sell
79,537
-12,438
-14% -$49K ﹤0.01% 2411
2025
Q4 		$375K Buy
91,975
+44,458
+94% +$199K ﹤0.01% 2286
2025
Q3 		$169K Sell
47,517
-242,894
-84% -$878K ﹤0.01% 2638
2025
Q2 		$793K Buy
290,411
+316
+0.1% +$652 ﹤0.01% 1933
2025
Q1 		$487K Sell
290,095
-18,127
-6% -$50.7K ﹤0.01% 2158
2024
Q4 		$502K Sell
308,222
-1,893
-0.6% -$5.64K ﹤0.01% 2238
2024
Q3 		$1.29M Sell
310,115
-1,916
-0.6% -$10.1K ﹤0.01% 1780
2024
Q2 		$1.7M Buy
312,031
+23,157
+8% +$185K ﹤0.01% 1556
2024
Q1 		$2.89M Buy
288,874
+25,397
+10% +$190K ﹤0.01% 1387
2023
Q4 		$1.07M Buy
263,477
+48,246
+22% +$178K ﹤0.01% 1760
2023
Q3 		$833K Buy
215,231
+11,399
+6% +$61.3K ﹤0.01% 1832
2023
Q2 		$1.21M Buy
203,832
+1,927
+1% +$11.1K ﹤0.01% 1565
2023
Q1 		$660K Sell
201,905
-1,411
-0.7% -$5.64K ﹤0.01% 1837
2022
Q4 		$777K Buy
203,316
+59,742
+42% +$292K ﹤0.01% 1735
2022
Q3 		$817K Sell
143,574
-639
-0.4% -$4.61K ﹤0.01% 1695
2022
Q2 		$908K Buy
144,213
+24,917
+21% +$159K ﹤0.01% 1693
2022
Q1 		$976K Buy
119,296
+73,561
+161% +$595K ﹤0.01% 1766
2021
Q4 		$713 Buy
45,735
+320
+0.7% +$6.17K ﹤0.01% 2036
2021
Q3 		$1.02M Buy
45,415
+27,979
+160% +$587K ﹤0.01% 1820
2021
Q2 		$343K Buy
+17,436
New +$395K ﹤0.01% 2713

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SANA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Sana Biotechnology (SANA) stake by 14% in Q1 2026, selling an estimated $49K and leaving 79,537 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Manulife (Manufacturers Life Insurance) first reported a position in SANA in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.89M in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 79,537 shares of Sana Biotechnology worth $229K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 12,438 Sana Biotechnology shares in Q1 2026, an estimated $49K.
  • Sana Biotechnology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2411 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sana Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Sana Biotechnology position peaked at $2.89M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.